Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.17 HKD
Change Today +0.01 / 0.46%
Volume 2.2M
As of 4:01 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by CHINA GRAND PHARMACEUTICAL A (512) in the last 6 months

Announced 04/21/15
73.00M for CARDIONOVUM GmbH
Merger/Acquisition

Shanghai Muyi Investment Management Partnership and China Grand Pharmaceutical and Healthcare Holdings Ltd. (SEHK:512) entered into an agreement to acquire 73% stake in Cardionovum GmbH from Michael Stefan Orlowski and Japan Lifeline Co., Ltd for $73 million on April 21, 2015. The purchase price shall be subject to any downward adjustment due to the shortfall of the actual net working capital of Cardionovum GmbH. Michael Stefan Orlowski and Japan Lifeline owns 90% and ...
Read More


512's price was unchanged after the transaction was announced on 04/21/15.
Investor / Buyer
China Grand Pharmaceutical and Healthcare Holdings Ltd.
Shanghai Muyi Investment Management Partnership
Creditor / Lender
Japan Lifeline Co., Ltd.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
512:HK $2.17 HKD +0.01

512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY73.46 CNY -0.14
View Industry Companies
 

Industry Analysis

512

Industry Average

Valuation 512 Industry Range
Price/Earnings 24.9x
Price/Sales 1.4x
Price/Book 3.8x
Price/Cash Flow 24.3x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA GRAND PHARMACEUTICAL A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.